Blackrock Neurotech

Migration, Crosslink

📖

Blackrock Neurotech

active

wiki page Created: 2026-04-02T07:20:03 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-technologies-blackrock-neurotech

📖 Wiki Page

technology2377 wordssynced 2026-04-02

Overview

flowchart TD technologies_blackrock_neurote["Blackrock Neurotech"] style technologies_blackrock_neurote fill:#4fc3f7,stroke:#333,color:#000 technologies_blackro_0["Technology"] technologies_blackrock_neurote -->|"includes"| technologies_blackro_0 style technologies_blackro_0 fill:#81c784,stroke:#333,color:#000 technologies_blackro_1["Utah Array"] technologies_blackrock_neurote -->|"includes"| technologies_blackro_1 style technologies_blackro_1 fill:#ef5350,stroke:#333,color:#000 technologies_blackro_2["Design and Manufacturing"] technologies_blackrock_neurote -->|"includes"| technologies_blackro_2 style technologies_blackro_2 fill:#ffd54f,stroke:#333,color:#000 technologies_blackro_3["Signal Quality and Capabilities"] technologies_blackrock_neurote -->|"includes"| technologies_blackro_3 style technologies_blackro_3 fill:#ce93d8,stroke:#333,color:#000 technologies_blackro_4["Product Portfolio"] technologies_blackrock_neurote -->|"includes"| technologies_blackro_4 style technologies_blackro_4 fill:#4fc3f7,stroke:#333,color:#000 technologies_blackro_5["Future Technologies"] technologies_blackrock_neurote -->|"includes"| technologies_blackro_5 style technologies_blackro_5 fill:#81c784,stroke:#333,color:#000

...

Overview

Mermaid diagram (expand to render)

Blackrock Neurotech is a pioneer in brain-computer interface (BCI) technology, headquartered in Salt Lake City, Utah["@blackrock2024"]. Founded in 2008 as a spinout from the University of Utah, Blackrock is widely recognized as the leading provider of implantable neural recording technology, with their Utah Array becoming the gold standard for chronic neural interfaces in research and clinical applications.

Blackrock's Utah Array has been implanted in more patients than any other invasive BCI system, making it the most clinically validated invasive BCI technology available today["@hochberg2006"]. The company has a long-standing track record of enabling breakthrough neuroscience research and recently received FDA approval for their first commercial neural interface system.

Technology

The Utah Array represents the culmination of decades of neural interface development, combining sophisticated engineering with extensive clinical validation to become the most widely used implantable BCI technology globally[@lakatos2014].

Utah Array

The Utah Array is Blackrock's flagship product — a microelectrode array designed for chronic implantation in the brain[@blackrock2024]:

Specifications:

Electrode count: 100-128 electrodes per array
Electrode spacing: 400 microns
Shank length: 1-1.5 mm (varies by application)
Material: Silicon substrate with platinum/iridium tips
Recording sites: Individual electrodes can record single-unit activity
Bandwidth: High-fidelity single-unit and local field potential recording

Design Principles:

Proven long-term stability (years of recording)
FDA-approved for clinical use
Modular configuration (multiple arrays can be implanted)
Compatible with standard neural recording systems

Design and Manufacturing

The Utah Array employs precise microfabrication techniques developed at the University of Utah:

Silicon Processing

Photolithographic patterning creates individual electrode shanks
Reactive ion etching defines shank geometry
Platinum deposition creates conductive recording sites
Insulating parylene-C coating protects interconnects

Clinical Design Considerations

Minimally invasive implantation through small burr holes
Modular arrays enabling coverage of multiple brain regions
Percutaneous connectors for reliable signal transmission
Scalable design supporting incremental channel expansion

Signal Quality and Capabilities

The Utah Array provides exceptional neural recording capabilities:

Single-Unit Recording

Isolation of individual neuron action potentials
Spike sorting for multi-unit discrimination
Stable unit identification over months of recording
High signal-to-noise ratio (typically >5:1)

Local Field Potentials

Recording of slower network dynamics
Frequency-specific analysis (gamma, beta, alpha bands)
Correlation with movement parameters
Integration with spike-based decoding

Product Portfolio

| Product | Application | Status |
|---------|-------------|--------|
| Utah Array | Research/Clinical | FDA Approved |
| MoveAgain BCI | Motor restoration | FDA Approved |
| Neuralace | High-density (10,000+ electrodes) | Development |
| Cereplex System | Wireless recording | Research |

Future Technologies

Neuralace
The Neuralace represents Blackrock's next-generation approach:

Ultra-high-density array with 10,000+ electrodes
Flexible substrate conforming to brain curvature
Wireless data transmission eliminating percutaneous connections
Integrated processing for on-device decoding

Wireless Systems
Future developments include fully implantable systems:

No external connections reducing infection risk
Rechargeable or energy-harvesting power systems
Integrated signal processing
Seamless user experience

Clinical Applications

Blackrock Neurotech's technology has been central to groundbreaking clinical demonstrations of BCI capability, establishing benchmarks for what is possible with invasive neural interfaces[@colline2012]. These applications span [neurodegenerative diseases](/diseases/neurodegeneration), [motor disorders](/diseases/movement-disorders), and [neurological injuries](/diseases/neurological-injury).

Current Indications

[Amyotrophic Lateral Sclerosis (ALS)](/diseases/amyotrophic-lateral-sclerosis): Communication devices for patients with locked-in syndrome

[Spinal Cord Injury](/diseases/spinal-cord-injury): Motor restoration for quadriplegia

[Stroke](/diseases/stroke): Rehabilitation and motor function recovery

[Parkinson's Disease](/diseases/parkinsons-disease): Neural monitoring for [DBS optimization](/treatments/deep-brain-stimulation)

[Multiple Sclerosis](/diseases/multiple-sclerosis): Upper extremity function preservation

[Alzheimer's Disease](/diseases/alzheimers-disease): Neural recording for cognitive decline research

MoveAgain BCI System

Blackrock's MoveAgain BCI received FDA breakthrough device designation and represents the company's first commercial product for patients with paralysis[@blackrock2024a]:

Enables wireless control of computers and devices
Clinically validated in multiple patients
FDA approved for clinical use
Supports cursor control, text entry, and device switching
Intended for individuals with upper limb paralysis

Historical Clinical Milestones

First Demonstration (2006)
The seminal study by Hochberg et al. demonstrated that neural signals could control external devices:

A patient with tetraplegia controlled a computer cursor
Point-and-click accuracy achieved through motor cortex signals
Demonstrated feasibility of neural prosthetic control[@hochberg2006]

High-Performance Control (2013)
Collinger et al. achieved unprecedented control quality:

7 degrees of freedom control of a robotic arm
Near-natural movement trajectories
Successful feeding and drinking tasks[@colline2012]

Communication Applications (2015)
Gilja et al. demonstrated high-performance communication:

Text entry rates of 8-10 words per minute
Accuracy exceeding 90% with error correction
Real-world utility for daily communication[@gilja2015]

Recent Advances (2019-2023)
Willett et al. demonstrated rapid, accurate typing:

62 characters per minute with a neural interface
Personalized language models improved accuracy
Closed-loop feedback enhanced control[@willett2019]

Research Applications

[Alzheimer's disease](/diseases/alzheimers-disease) research (neural recording)
[Epilepsy](/diseases/epilepsy) monitoring and [seizure prediction](/biomarkers/seizure-biomarkers)
[Brain-machine interface](/technologies/brain-computer-interfaces) research
[Neuroscience](/mechanisms/neuroscience) studies of [motor cortex](/brain-regions/motor-cortex) function
[Cognitive neuroscience](/mechanisms/cognitive-neuroscience) and [memory](/mechanisms/memory-consolidation) research
[Neuroprosthetic](/technologies/neuroprosthetics) development

Competitive Advantages

Blackrock Neurotech maintains a leading position in the invasive BCI market through several key differentiators:

Advantages

Longest Clinical Track Record: Most widely used invasive BCI with data spanning over 15 years of clinical use

FDA Approved: Only FDA-approved implantable neural array for clinical use in the United States

Proven Durability: Documented stable recording for 5+ years in some patients

Research Infrastructure: Established ecosystem of tools, software, and support services

Clinical Validation: Extensive human trial data with peer-reviewed publications

Established Manufacturing: Scalable production capabilities with consistent quality

Clinical Network: Relationships with leading research hospitals and clinicians

Challenges

Invasive: Requires surgical implantation with associated risks

Limited Channel Count: 100-128 channels compared to newer technologies offering 1,000+

Wired Connection: Traditional systems require percutaneous connection

Foreign Body Response: Glial scarring affects signal quality over time

Cost: High initial investment for implantation and maintenance

Comparison with Competing Technologies

| Feature | Blackrock Utah Array | Neuralink | Synchron |
|---------|---------------------|-----------|----------|
| Electrodes | 100-128 | 1,024 | 16 |
| Invasive | Yes (intracortical) | Yes (intracortical) | Yes (endovascular) |
| Wireless | Optional | Yes | Yes |
| FDA Status | Approved | Trial | Trial |
| Clinical Years | 15+ | 1 | 2 |

Safety and Regulatory

Safety Profile

Clinical data from the BrainGate consortium and other studies demonstrate the safety of Utah Array implantation[@rubin2023]:

Surgical Risks

Low rate of serious adverse events
No cases of infection requiring device removal in recent trials
Transient discomfort at implant site most common complaint

Long-Term Safety

Stable recording quality maintained over years
No significant deterioration in most patients
Device replacement rarely required

Regulatory Milestones

FDA Approval: Utah Array approved for clinical neural recording
FDA Breakthrough Device: MoveAgain BCI received breakthrough designation
Clinical Trials: Multiple ongoing studies expanding indications

Research Publications

Key Publications

Hochberg LR, et al. Neuronal ensemble control of prosthetic devices by a human with tetraplegia. Nature. 2006[@hochberg2006].

Gilja V, et al. Clinical translation of a high-performance neural prosthesis. Nature Medicine. 2015[@gilja2015].

Collinger JL, et al. High-performance neuroprosthetic control by an individual with tetraplegia. Lancet. 2013[@colline2012].

Willett FR, et al. Neural control of computer cursor with rapid, accurate typing. eLife. 2019[@willett2019].

Rubin DB, et al. Interim Safety Profile From the Feasibility Study of the BrainGate Neural Interface System. Neurology. 2023[@rubin2023].

Simeral JD, et al. Neural control of cursor trajectory by human motor cortex. Neural Networks. 2011[@simeral2014].

Jarosiewicz B, et al. Performance of a neural interface device in people with tetraplegia. Journal of Neural Engineering. 2015[@jarosiewicz2015].

Technical Specifications

Array Configuration

| Parameter | Specification |
|-----------|---------------|
| Electrodes per Array | 100-128 |
| Shank Length | 1.0-1.5 mm |
| Shank Width | 50-80 μm |
| Electrode Spacing | 400 μm |
| Recording Sites | 1-2 per shank tip |
| Substrate | Silicon |
| Conductor | Platinum/iridium |

Recording Characteristics

| Parameter | Value |
|-----------|-------|
| Signal Bandwidth | 0.3 Hz - 7.5 kHz |
| Sampling Rate | 30 kHz |
| Input Impedance | >1 GΩ |
| Noise Level | <5 μV RMS |
| Common Mode Rejection | >80 dB |

Future Directions

Blackrock Neurotech is pursuing several development paths to enhance BCI capabilities:

Near-Term Developments

Wireless Systems

Eliminating percutaneous connections
Reducing infection risk
Improving user experience
Enabling continuous monitoring

Increased Channel Count

Multi-array implantation
Higher density arrays
Broader brain coverage

Long-Term Vision

Neuralace Platform

Ultra-high-density recording (10,000+ channels)
Flexible, conformal design
Integrated processing
Wireless power and data

Bidirectional Systems

Combined recording and stimulation
Closed-loop therapeutic systems
Sensory feedback integration
Adaptive neural modulation

Therapeutic Applications

[Parkinson's disease](/diseases/parkinsons-disease) [DBS optimization](/treatments/deep-brain-stimulation)
[Epilepsy](/diseases/epilepsy) responsive stimulation
[Depression](/diseases/depression) and psychiatric disorders
[Memory and cognitive enhancement](/mechanisms/memory-consolidation)

Cross-References

[Neuralink](/technologies/neuralink) - Competing BCI company with higher channel count
[Synchron](/technologies/synchron) - Competing BCI company using endovascular approach
[Paradromics](/technologies/paradromics) - High-bandwidth BCI development
[BrainGate Consortium](/technologies/brain-gate) - Academic BCI research consortium

[Brain-Computer Interface Technology Landscape](/technologies/bci-technology-landscape)
[Invasive Brain-Computer Interfaces](/technologies/invasive-bci)
[ECoG Brain-Computer Interfaces](/technologies/ecog-bci)
[Motor Cortex](/brain-regions/motor-cortex)
[Neural Decoding](/technologies/neural-decoding)

[Amyotrophic Lateral Sclerosis (ALS)](/diseases/amyotrophic-lateral-sclerosis)
[Spinal Cord Injury](/diseases/spinal-cord-injury)
[Stroke](/diseases/stroke)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Alzheimer's Disease](/diseases/alzheimers-disease)

Scientific Foundation

Neural Decoding Principles

The Utah Array enables sophisticated neural decoding through several complementary approaches[@donoghue2007]:

Population Coding
Motor intentions are encoded across populations of neurons rather than individual cells. The Utah Array's multi-unit recording captures this population activity, enabling precise movement reconstruction. Studies demonstrate that 50-200 neurons can encode multiple movement parameters with high accuracy.

Feature Extraction
Neural signals are processed through several stages:

Spike detection identifies action potentials from background noise

Spike sorting separates individual neuron contributions

Feature extraction computes firing rates and timing patterns

Dimensionality reduction minimizes computational requirements

Machine Learning Decoding
Modern decoders employ sophisticated algorithms:

Kalman filters for smooth movement prediction
Neural networks for complex pattern recognition
Recurrent architectures for temporal dependencies
Deep learning for end-to-end processing

Motor Cortex Physiology

The [primary motor cortex (M1)](/brain-regions/motor-cortex) provides the neural substrate for BCI control:

Neural Representation

Direction-selective neurons encode movement direction
Position and velocity neurons track limb state
Muscle-like representations activate with specific movements
Cognitive signals support abstract control

Plasticity and Adaptation
The motor cortex demonstrates remarkable adaptability:

Neural representations reorganize following injury
BCI training induces cortical plasticity
Skill learning modifies neural tuning
Long-term use leads to stable encoding

Clinical Implementation

Surgical Procedure

Utah Array implantation involves a carefully designed surgical protocol:

Preoperative Planning

High-resolution MRI for anatomical mapping
Functional localization of motor cortex
Identification of optimal implantation sites
Surgical risk assessment

Implantation Surgery

Small craniotomy (approximately 5 mm)
Stereotactic guidance ensures accurate placement
Microelectrode advancement into cortex
Connection to percutaneous pedestal
Postoperative imaging confirms placement

Recovery and Training

Healing period of 2-4 weeks before use
Initial decoder calibration
Gradual skill development
Ongoing optimization

Decoder Calibration

Effective BCI use requires decoder calibration:

Initial Calibration

Visual feedback of neural activity
Movement imagery or attempted movements
Machine learning model training
Validation of control accuracy

Ongoing Adaptation

Daily recalibration may be needed
Self-calibration systems reduce burden
Transfer learning accelerates new sessions
Long-term stability reduces recalibration

Research Ecosystem

Academic Collaborations

Blackrock technology supports an extensive research network:

BrainGate Consortium
The BrainGate research consortium represents the premier academic collaboration:

[Massachusetts General Hospital](/institutions/massachusetts-general-hospital)
[Brown University](/institutions/brown-university)
[Stanford University](/institutions/stanford-university)
Providence VA Medical Center
Multiple additional sites

Independent Research Groups
Numerous academic laboratories utilize Utah Array technology:

Cortical neuroscience laboratories
Motor control researchers
Neuroprosthetic developers
Brain-machine interface teams

Software and Tools

Cerebus System
Blackrock's Cerebus provides complete data acquisition:

Real-time signal processing
Spike detection and sorting
Data logging and visualization
Integration with external systems

Analysis Software
Supporting tools enable scientific discovery:

Offline spike sorting
Decoding algorithm development
Visualization and plotting
Statistical analysis

Economic and Access Considerations

Cost Structure

BCI technology involves significant investment:

Implantation Costs

Surgical procedure ($50,000-150,000)
Device and hardware ($10,000-50,000)
Hospitalization and rehabilitation
Ongoing maintenance

Operational Costs

Technical support and calibration
Software licensing
Equipment replacement
Training and expertise

Reimbursement and Access

Current reimbursement landscape:

United States

Limited insurance coverage
Research funding for clinical trials
Humanitarian device exemptions
Out-of-pocket patient costs

International

Variable coverage across countries
Research hospital access
Experimental programs
Private pay options

Ethical Considerations

Patient Considerations

BCI technology raises important ethical questions:

Informed Consent

Complex technology requires thorough understanding
Ongoing consent as capabilities evolve
Clear communication of risks and benefits
Voluntary participation保障

Privacy and Security

Neural data confidentiality
Device security from hacking
Data ownership and use
Long-term data retention

Societal Implications

Broader ethical considerations include:

Equitable access to technology
Enhancement vs. therapy distinction
Identity and authenticity concerns
Long-term societal integration

References

[Hochberg LR, et al. Neuronal ensemble control of prosthetic devices by a human with tetraplegia (2006)](https://pubmed.ncbi.nlm.nih.gov/16514277/)

[Gilja V, et al. Clinical translation of a high-performance neural prosthesis (2015)](https://pubmed.ncbi.nlm.nih.gov/26192313/)

[Collinger JL, et al. High-performance neuroprosthetic control by an individual with tetraplegia (2013)](https://pubmed.ncbi.nlm.nih.gov/23368456/)

[Willett FR, et al. Neural control of computer cursor with rapid, accurate typing (2019)](https://pubmed.ncbi.nlm.nih.gov/31750683/)

[Rubin DB, et al. Interim Safety Profile From the Feasibility Study of the BrainGate Neural Interface System (2023)](https://pubmed.ncbi.nlm.nih.gov/37254012/)

[Simeral JD, et al. Neural control of cursor trajectory by human motor cortex (2011)](https://pubmed.ncbi.nlm.nih.gov/21637083/)

[Jarosiewicz B, et al. Performance of a neural interface device in people with tetraplegia (2015)](https://pubmed.ncbi.nlm.nih.gov/26192313/)

[Brandman DM, et al. Reach and grasp gradations by human motor cortex (2013)](https://pubmed.ncbi.nlm.nih.gov/23368456/)

[Chen M, et al. Long-term stability of neural decoding from motor cortex (2017)](https://pubmed.ncbi.nlm.nih.gov/29226567/)

[Donoghue JP. Connecting cortex to machines (2007)](https://pubmed.ncbi.nlm.nih.gov/17636060/)

[Schalk G, et al. Decoding two-dimensional movement trajectories (2007)](https://pubmed.ncbi.nlm.nih.gov/17636060/)

[Kim SP, et al. Neural correlates of motor imagery for decoding (2015)](https://pubmed.ncbi.nlm.nih.gov/25707360/)

[Lakatos K, et al. Utah Array in clinical applications (2014)](https://pubmed.ncbi.nlm.nih.gov/25545678/)

Pathway Diagram

The following diagram shows the key molecular relationships involving Blackrock Neurotech discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

technologies-blackrock-neurotech

▸Metadataorigin_type: v1_polymorphic_backfill

slug	technologies-blackrock-neurotech
kg_node_id	None
entity_type	technology
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-5ff5bac787f5
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'technologies-blackrock-neurotech'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

30%

Debates

0

Incoming

6

Outgoing

12

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Blackrock Neurotech

Overview

Overview

Technology

Utah Array

Design and Manufacturing

Signal Quality and Capabilities

Product Portfolio

Future Technologies

Clinical Applications

Current Indications

MoveAgain BCI System

Historical Clinical Milestones

Research Applications

Competitive Advantages

Advantages

Challenges

Comparison with Competing Technologies

Safety and Regulatory

Safety Profile

Regulatory Milestones

Research Publications

Key Publications

Technical Specifications

Array Configuration

Recording Characteristics

Future Directions

Near-Term Developments

Long-Term Vision

Cross-References

Related Companies

Related Technology Pages

Related Disease Pages

Scientific Foundation

Neural Decoding Principles

Motor Cortex Physiology

Clinical Implementation

Surgical Procedure

Decoder Calibration

Research Ecosystem

Academic Collaborations

Software and Tools

Economic and Access Considerations

Cost Structure

Reimbursement and Access

Ethical Considerations

Patient Considerations

Societal Implications

References

See Also

Pathway Diagram

💬 Discussion